20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. ... 20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. The company was incorporated in 2000 and is based in Gaithersburg, Maryland. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0399 | 7.12372790573 | 0.5601 | 0.7 | 0.5111 | 556891 | 0.5985446 | CS |
| 4 | -0.26 | -30.2325581395 | 0.86 | 0.989 | 0.5111 | 1832640 | 0.86101653 | CS |
| 12 | -1.27 | -67.9144385027 | 1.87 | 1.99 | 0.5111 | 826634 | 0.91859554 | CS |
| 26 | -18.8 | -96.9072164948 | 19.4 | 19.4 | 0.5111 | 659012 | 1.46089337 | CS |
| 52 | -18.8 | -96.9072164948 | 19.4 | 19.4 | 0.5111 | 659012 | 1.46089337 | CS |
| 156 | -18.8 | -96.9072164948 | 19.4 | 19.4 | 0.5111 | 659012 | 1.46089337 | CS |
| 260 | -18.8 | -96.9072164948 | 19.4 | 19.4 | 0.5111 | 659012 | 1.46089337 | CS |
jxyzobrien
22分前
eagle8
24分前
Mrs kronwell
26分前
superman2026
28分前
gregcod
35分前
t1215s
38分前
gregcod
53分前
sage007
57分前
FlashySage44
1時間前
ulmadi
1時間前
Methinks
2時間前
EZ2
2時間前
t1215s
2時間前
Golfnut3
2時間前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。